Presentation is loading. Please wait.

Presentation is loading. Please wait.

INSULIN THEARPY BY DR ROMNESH DE SOUZA. Insulin (from Latin insula, "island", as it is produced in the Islets of Langerhans in the pancreas) is an anabolic.

Similar presentations


Presentation on theme: "INSULIN THEARPY BY DR ROMNESH DE SOUZA. Insulin (from Latin insula, "island", as it is produced in the Islets of Langerhans in the pancreas) is an anabolic."— Presentation transcript:

1 INSULIN THEARPY BY DR ROMNESH DE SOUZA

2 Insulin (from Latin insula, "island", as it is produced in the Islets of Langerhans in the pancreas) is an anabolic polypeptide hormone that regulates carbohydrate metabolism. Apart from being the primary agent in carbohydrate homeostasis, it has effects on fat metabolism and it changes the liver's activity in storing or releasing glucose and in processing blood lipids, and in other tissues such as fat and muscle. The amount of insulin in circulation has extremely widespread effects throughout the body. Insulin (from Latin insula, "island", as it is produced in the Islets of Langerhans in the pancreas) is an anabolic polypeptide hormone that regulates carbohydrate metabolism. Apart from being the primary agent in carbohydrate homeostasis, it has effects on fat metabolism and it changes the liver's activity in storing or releasing glucose and in processing blood lipids, and in other tissues such as fat and muscle. The amount of insulin in circulation has extremely widespread effects throughout the body.LatinIslets of Langerhanspancreasanabolic polypeptidehormonecarbohydrate metabolism carbohydratehomeostasisLatinIslets of Langerhanspancreasanabolic polypeptidehormonecarbohydrate metabolism carbohydratehomeostasis

3 The actions of insulin on the global human metabolism level include: The actions of insulin on the global human metabolism level include: Control of cellular intake of certain substances, most prominently glucose in muscle and adipose tissue (about of body cells). Control of cellular intake of certain substances, most prominently glucose in muscle and adipose tissue (about of body cells).glucose Increase of DNA replication and protein synthesis via control of amino acid uptake. Increase of DNA replication and protein synthesis via control of amino acid uptake.DNA replicationprotein synthesisDNA replicationprotein synthesis Modification of the activity of numerous enzymes (allosteric effect). Modification of the activity of numerous enzymes (allosteric effect).enzymesallosteric effectenzymesallosteric effect The actions of insulin on cells include: The actions of insulin on cells include: Increased glycogen synthesis - insulin forces storage of glucose in liver (and muscle) cells in the form of glycogen; lowered levels of insulin cause liver cells to convert glycogen to glucose and excrete it into the blood. This is the clinical action of insulin which is directly useful in reducing high blood glucose levels as in diabetes. Increased glycogen synthesis - insulin forces storage of glucose in liver (and muscle) cells in the form of glycogen; lowered levels of insulin cause liver cells to convert glycogen to glucose and excrete it into the blood. This is the clinical action of insulin which is directly useful in reducing high blood glucose levels as in diabetes.glycogen Increased fatty acid synthesis - insulin forces fat cells to take in blood lipids which are converted to triglycerides; lack of insulin causes the reverse. Increased fatty acid synthesis - insulin forces fat cells to take in blood lipids which are converted to triglycerides; lack of insulin causes the reverse.fatty acidtriglyceridesfatty acidtriglycerides

4 Increased esterification of fatty acids - forces adipose tissue to make fats (ie, triglycerides) from fatty acid esters; lack of insulin causes the reverse. Increased esterification of fatty acids - forces adipose tissue to make fats (ie, triglycerides) from fatty acid esters; lack of insulin causes the reverse.adipose tissueadipose tissue Decreased proteinolysis - forces reduction of protein degradation; lack of insulin increases protein degradation. Decreased proteinolysis - forces reduction of protein degradation; lack of insulin increases protein degradation.proteinolysis Decreased lipolysis - forces reduction in conversion of fat cell lipid stores into blood fatty acids; lack of insulin causes the reverse. Decreased lipolysis - forces reduction in conversion of fat cell lipid stores into blood fatty acids; lack of insulin causes the reverse.lipolysis Decreased gluconeogenesis - decreases production of glucose from various substrates in liver; lack of insulin causes glucose production from assorted substrates in the liver and elsewhere. Decreased gluconeogenesis - decreases production of glucose from various substrates in liver; lack of insulin causes glucose production from assorted substrates in the liver and elsewhere.gluconeogenesis Increased amino acid uptake - forces cells to absorb circulating amino acids; lack of insulin inhibits absorption. Increased amino acid uptake - forces cells to absorb circulating amino acids; lack of insulin inhibits absorption. Increased potassium uptake - forces cells to absorb serum potassium; lack of insulin inhibits absorption. Increased potassium uptake - forces cells to absorb serum potassium; lack of insulin inhibits absorption. Arterial muscle tone - forces arterial wall muscle to relax, increasing blood flow, especially in micro arteries; lack of insulin reduces flow by allowing these muscles to contract. Arterial muscle tone - forces arterial wall muscle to relax, increasing blood flow, especially in micro arteries; lack of insulin reduces flow by allowing these muscles to contract.

5 Effect of insulin on glucose uptake and metabolism. Insulin binds to its receptor (1) which in turn starts many protein activation cascades (2). These include: translocation of Glut-4 transporter to the plasma membrane and influx of glucose (3), glycogen synthesis (4), glycolysis (5) and fatty acid synthesis (6). Effect of insulin on glucose uptake and metabolism. Insulin binds to its receptor (1) which in turn starts many protein activation cascades (2). These include: translocation of Glut-4 transporter to the plasma membrane and influx of glucose (3), glycogen synthesis (4), glycolysis (5) and fatty acid synthesis (6).plasma membrane glycogenglycolysisfatty acidplasma membrane glycogenglycolysisfatty acid

6 TYPES OF INSULIN Quick-acting, such as the insulin analog lispro -- begins to work within 5 to 15 minutes and is active for 3 to 4 hours. Quick-acting, such as the insulin analog lispro -- begins to work within 5 to 15 minutes and is active for 3 to 4 hours. Short-acting, such as regular insulin -- starts working within 30 minutes and is active about 5 to 8 hours. Short-acting, such as regular insulin -- starts working within 30 minutes and is active about 5 to 8 hours. Intermediate-acting, such as NPH, or lente insulin -- starts working in 1 to 3 hours and is active 16 to 24 hours. Intermediate-acting, such as NPH, or lente insulin -- starts working in 1 to 3 hours and is active 16 to 24 hours.NPH Long-acting, such as ultralente insulin -- starts working in 4 to 6 hours, and is active 24 to 28 hours. Long-acting, such as ultralente insulin -- starts working in 4 to 6 hours, and is active 24 to 28 hours. Insulin glargine and Insulin detemir -- both insulin analogs which start working within 1 to 2 hours and continue to be active, without peaks or dips, for about 24 hours. Insulin glargine and Insulin detemir -- both insulin analogs which start working within 1 to 2 hours and continue to be active, without peaks or dips, for about 24 hours. A mixture of NPH and regular insulin -- starts working in 30 minutes and is active 16 to 24 hours. There are several variations with different proportions of the mixed insulins. A mixture of NPH and regular insulin -- starts working in 30 minutes and is active 16 to 24 hours. There are several variations with different proportions of the mixed insulins.

7 Syringes Syringes Insulin pens Insulin pens Injection aids Injection aids Jet injectors Jet injectors External insulin pumps External insulin pumps Implantable Insulin Pumps Implantable Insulin Pumps Insulin Inhalers Insulin Inhalers

8 DIABETIC KETO ACIDOSIS

9 Diabetic ketoacidosis consists of a biochemical triad of- a) hyperglycemia Diabetic ketoacidosis consists of a biochemical triad of- a) hyperglycemia b) ketonemia c) acidemia

10 EMPERICAL CLASSIFICATION OF DKA MILDMODERATESEVERE Plasma glucose >250>250>250 Arterial Ph <7.0 Serum Bicarb <10 Anion gap >10>12>12 SensoriumalertAlert/drowsyStupor/coma

11 SYMPTOMS Excessive thirst or urination Excessive thirst or urination Weakness and fatigue Weakness and fatigue Deep, slow breathing Deep, slow breathing Nausea, vomiting and stomach pain Nausea, vomiting and stomach pain Decreased appetite and weight loss Decreased appetite and weight loss Fruity-scented breath (caused by high ketone levels Fruity-scented breath (caused by high ketone levels

12 PRECIPITATING FACTORS DIABETES MELLITUS – uncontrolled DIABETES MELLITUS – uncontrolled - discontinuation of insulin - newly diagnosed ACUTE ILLNESS - infections - MI - CVA - GI Bleed - Renal failure DRUGS - Thiazides,glucocoricoids,beta blockers,phenytoin blockers,phenytoin SUBSTANCE ABUSE- alchol, cocaine

13 PATHOGENESIS The basic underlying mechanism for DKA is insulin deficiency, either relative or absolute, along with elevation pf counter regulatory hormones such as glucagon, catecholamines,cortisol and growth hormones. The basic underlying mechanism for DKA is insulin deficiency, either relative or absolute, along with elevation pf counter regulatory hormones such as glucagon, catecholamines,cortisol and growth hormones.

14 LAB INVESTIGATIONS CBC CBC RBS RBS ABG ABG Renal function tests Renal function tests Sr electrolytes Sr electrolytes Urine Analysis and ketones Urine Analysis and ketones X ray chest, ECG X ray chest, ECG

15 FORMULAE Anion gap Anion gap[Na]-[Cl+HCO3] nomal- 7-9mEq/L nomal- 7-9mEq/L SERUM OSMOLALITY 2*[Na]+(glucose in mg/dl)/18 + BUN in mg/dl/2.8 Normal – Na HcCO3 Deficit Calculation.6*soda bicarb deficit * body weight/2

16 MANAGEMENT Replace fluid losses Replace fluid losses Correction of hyperglucemia Correction of hyperglucemia Replacement of electrolyte losses Replacement of electrolyte losses Detection and treatment of the cause Detection and treatment of the cause Prevent recurrence Prevent recurrence

17 Fluid replacement Initially 1 L hydration corrected corrected serum Na Value High/ When the plasma glucose reaches add dextrose + insulin+ KCL to drip, maintain plasma

18 POTASSIUM CORRECTION SERUM POTTASIUM IV FLUID POT (mEq/l) <

19 INSULIN THEARPY REGULAR INSULIN IV ROUTESC/IM ROUTE 0.15U/kg as iv bolus.4U/kg ½ as iv,1/2SC.1U/kg/hr as IV infusion.1U/kg/hr SC/IM If plasma glucose does not fall by 50-70m/dl in the first hour then Double rate of infusion till it doesgive IV 10U bolus/hr when plasma glucose reaches 250 start tapering insulin infusion at the same time start SC insulin. Pump not to be stopped suddenly. And start glucose insulin pot drip

20 GENERAL Monitor plasma glucose, urine ketones and sugars every hour till plasma glucose reaches 250 Monitor plasma glucose, urine ketones and sugars every hour till plasma glucose reaches 250 Look for precipating factor such as UTI and treat Look for precipating factor such as UTI and treat


Download ppt "INSULIN THEARPY BY DR ROMNESH DE SOUZA. Insulin (from Latin insula, "island", as it is produced in the Islets of Langerhans in the pancreas) is an anabolic."

Similar presentations


Ads by Google